Tag: denosumab
Multiple Myeloma: Understanding Bone Disease and the Rise of Novel Treatments
Multiple myeloma causes severe bone damage in over 80% of patients. Learn how new drugs are shifting from preventing bone loss to actually healing fractures - and what patients need to know now.
read morerecent posts
Patent expiry means cheaper drugs-but only if you're prepared. Learn how patients and healthcare systems can save money and avoid disruptions when brand-name drugs go generic.
Published ON: 12 JanPartial AUC is a precise pharmacokinetic tool used to assess bioequivalence in complex drug formulations. Unlike total AUC, it focuses on specific time windows critical for drug effectiveness and safety-especially for extended-release and abuse-deterrent products. Regulators like the FDA now require it for over 127 drug products.
Published ON: 29 JanLong-term steroid use suppresses natural cortisol production. ACTH stimulation testing is the only reliable way to safely determine when your adrenal glands have recovered enough to stop replacement therapy. This guide explains how the test works, when to do it, and why skipping it can be life-threatening.
Published ON: 17 JanGeneric drug recalls happen when manufacturing failures threaten patient safety. Learn what triggers them-sterility issues, labeling errors, potency problems-and how the FDA responds. Find out why foreign factories are the biggest risk and what you can do to stay safe.
Published ON: 22 JanFeNO testing measures airway inflammation in asthma by detecting nitric oxide in exhaled breath. It helps doctors confirm diagnosis, adjust treatment, and reduce flare-ups with objective, non-invasive data.
Published ON: 14 Jan